First valsartan/amlodipine fixed dose combination tablet now available
AbstractNovartis Pharmaceuticals is proud to announce the launch of EXFORGE®, the first valsartan/amlodipine fixed dose combination tablet available in South Africa.1 This is used for the treatment of mild to moderate essential hypertension in patients whose blood pressure is normalised with the individual components in the same doses as the proposed fixed dose combination of EXFORGE®.
By submitting manuscripts to SAPJ, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPJ for educational and research purposes without obtaining permission.